Charles Schwab’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Charles Schwab’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-216,012	Closed	-$22M	–	3668
2023 Q2	$22M	Buy	216,012 +9,187	+4%	+$937K	0.01%	1422
2023 Q1	$18.8M	Buy	206,825 +805	+0.4%	+$73.2K	0.01%	1519
2022 Q4	$7.83M	Buy	206,020 +3,461	+2%	+$131K	﹤0.01%	1986
2022 Q3	$5.09M	Buy	202,559 +7,549	+4%	+$190K	﹤0.01%	2208
2022 Q2	$5.93M	Sell	195,010 -5,143	-3%	-$156K	﹤0.01%	2116
2022 Q1	$6.56M	Buy	200,153 +6,526	+3%	+$214K	﹤0.01%	2156
2021 Q4	$5.11M	Buy	193,627 +3,063	+2%	+$80.8K	﹤0.01%	2341
2021 Q3	$19.2M	Buy	190,564 +4,929	+3%	+$496K	0.01%	1626
2021 Q2	$26.3M	Buy	185,635 +59,185	+47%	+$8.38M	0.01%	1356
2021 Q1	$12.6M	Sell	126,450 -4,308	-3%	-$430K	﹤0.01%	1822
2020 Q4	$16.2M	Buy	130,758 +12,372	+10%	+$1.53M	0.01%	1555
2020 Q3	$11.5M	Sell	118,386 -12,285	-9%	-$1.2M	0.01%	1587
2020 Q2	$20.4M	Sell	130,671 -32,448	-20%	-$5.06M	0.01%	1153
2020 Q1	$23.5M	Buy	163,119 +12,978	+9%	+$1.87M	0.01%	907
2019 Q4	$30.7M	Buy	150,141 +16,913	+13%	+$3.46M	0.02%	930
2019 Q3	$10.7M	Buy	133,228 +31,902	+31%	+$2.56M	0.01%	1569
2019 Q2	$9.56M	Buy	101,326 +5,016	+5%	+$473K	0.01%	1615
2019 Q1	$8.23M	Buy	96,310 +4,917	+5%	+$420K	0.01%	1712
2018 Q4	$5.13M	Sell	91,393 -296	-0.3%	-$16.6K	﹤0.01%	1891
2018 Q3	$7.5M	Buy	91,689 +20,987	+30%	+$1.72M	0.01%	1817
2018 Q2	$2.47M	Buy	70,702 +21,244	+43%	+$743K	﹤0.01%	2307
2018 Q1	$1.02M	Buy	49,458 +1,404	+3%	+$28.8K	﹤0.01%	2508
2017 Q4	$1.36M	Sell	48,054 -1,774	-4%	-$50.2K	﹤0.01%	2434
2017 Q3	$1.55M	Buy	49,828 +22,628	+83%	+$704K	﹤0.01%	2368
2017 Q2	$861K	Buy	27,200 +8,400	+45%	+$266K	﹤0.01%	2508
2017 Q1	$426K	Hold	18,800	–	–	﹤0.01%	2701
2016 Q4	$411K	Buy	18,800 +9,700	+107%	+$212K	﹤0.01%	2720
2016 Q3	$240K	Buy	+9,100	New	+$240K	﹤0.01%	2865